• For full details of graphics available/in preparation, see Menu -> Planners
 U.S. Anstieg von Syphilis infographic
Graphic zeigt die Zunahme von Syphilis zwischen 2000 und 2021.


Syphilis steigt in US,, das Medikament geht zu Ende

By Duncan Mil

July 28, 2023 - Verknappung von Penicillin zur Behandlung von Syphilis Fällen ist stark angestiegen, sodass US Gesundheitsbehörden vor der epidemisch sexuell übertragbaren Infektion warnen.

The shortage of Pfizer’s penicillin G benzathine -- the preferred treatment for primary and secondary syphilis -- began in April.

Pfizer, the only company that makes prefilled syringes of penicillin for the United States, selling it under the brand name Bicillin L-A, says Bicillin will be back in stock by the second quarter of 2024.

Doctors canturn to another antibiotic, doxycycline, but that’s less convenient for patients. Doxycycline is a pill given twice a day for at least two weeks, whereas penicillin G benzathine can sometimes clear the disease completely with one injection.

“This is a remarkable shortage,” said Joseph Cherabie, who specializes in sexual health care at Saint Louis University School of Medicine.

Since 2000, cases of syphilis have been surging, reaching 53,767 primary and secondary cases in 2021, an increase of nearly 900 per cent, data from the Centers for Disease Control (CDC) show.

The U.S. government’s response is being led by Assistant Secretary for Health Admiral Rachel Levine. She is recruiting experts to tackle the crisis, including officials at the CDC, and is considering declaring a public health emergency.

PUBLISHED: 28/07/2023; STORY: Graphic News; PICTURES: McKesson Corporation, NIAID